Discontinuation of two different depot antipsychotics

This week, UK medical professionals were alerted of the permanent discontinuation of the supply of MODECATE (fluphenazine decanoate) injection by the end of 2018:

In October 2014, UK medical professionals were informed of permanent discontinuation of PIPORTIL Depot (pipothiazine palmitate):

Advice is given with these notifications of alternative depot medications. In changing patients from one depot to another I have found that there can be severe deterioration in mental health and that this can endure far beyond the transition phase.

My concern is that patients may be started on long-term medication without realising (being informed) that the medication they are taking may not be available at a future time and that this may have consequences for them. We must also consider that depot antipsychotics can be given without consent if certain criteria of mental health legislation are met.

 

One Reply to “Discontinuation of two different depot antipsychotics”

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.